{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:58:26Z","timestamp":1791305906623,"version":"4.3.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.contraception.2008.04.004","type":"journal-article","created":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T19:33:31Z","timestamp":1215459211000},"page":"201-203","source":"Crossref","is-referenced-by-count":16,"title":["Sex hormone-binding globulin: not a surrogate marker for venous thromboembolism in women using oral contraceptives"],"prefix":"10.1016","volume":"78","author":[{"given":"Frank Z.","family":"Stanczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2008.04.004_bib1","first-page":"482","article-title":"Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?","volume":"81","author":"Odlind","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2008.04.004_bib2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9378(03)00950-5","article-title":"Sex hormone-binding globulin \u2014 a surrogate marker for the prothrombotic effects of combined oral contraceptives","volume":"190","author":"van Rooijen","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2008.04.004_bib3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/humrep\/deh612","article-title":"Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens","volume":"20","author":"van Vliet","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2008.04.004_bib4","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/01.AOG.0000157445.67309.19","article-title":"Surrogate end points in clinical research: hazardous to your health","volume":"105","author":"Grimes","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2008.04.004_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1677\/joe.0.1750113","article-title":"Sex hormone-binding globulin is synthesized in target cells","volume":"175","author":"Kahn","year":"2002","journal-title":"J Endocrinol"},{"key":"10.1016\/j.contraception.2008.04.004_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0889-8529(18)30240-8","article-title":"Plasma steroid-binding proteins","volume":"20","author":"Rosner","year":"1991","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.contraception.2008.04.004_bib7","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1471-0528.1981.tb01202.x","article-title":"Maternal serum levels of sex steroid-binding protein during pregnancy","volume":"88","author":"Uriel","year":"1981","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2008.04.004_bib8","series-title":"Steroid\u2013protein interactions II","first-page":"320","author":"Westphal","year":"1986"},{"key":"10.1016\/j.contraception.2008.04.004_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/j.1939-4640.1988.tb01038.x","article-title":"Serum levels of total testosterone and sex hormone binding globulin in hypothyroid patients and normal subjects treated with incremental doses of L-T4 or L-T3","volume":"9","author":"Cavaliere","year":"1988","journal-title":"J Androl"},{"key":"10.1016\/j.contraception.2008.04.004_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/003693308503000206","article-title":"Hormone binding globulins and anticonvulsant therapy","volume":"30","author":"Beastall","year":"1985","journal-title":"Scott Med J"},{"key":"10.1016\/j.contraception.2008.04.004_bib11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/jcem-32-6-717","article-title":"Plasma testosterone binding globulin and indexes of the concentration of unbound plasma androgens in normal and hirsute subjects","volume":"32","author":"Rosenfield","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2008.04.004_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2265.1981.tb00644.x","article-title":"The effect of weight loss on sex steroid secretion and binding in massively obese women","volume":"15","author":"Kopelman","year":"1981","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.contraception.2008.04.004_bib13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0026-0495(88)90091-1","article-title":"The relationship of sex hormones to hyperinsulinemia and hyperglycemia","volume":"37","author":"Haffner","year":"1988","journal-title":"Metabolism"},{"key":"10.1016\/j.contraception.2008.04.004_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0015-0282(16)47956-2","article-title":"Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel","volume":"42","author":"Hammond","year":"1984","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2008.04.004_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2133.1982.tb04553.x","article-title":"Circulating testosterone, sex hormone binding globulin and prolactin in women with late onset or persistent acne vulgaris","volume":"106","author":"Darley","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.contraception.2008.04.004_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/00016348409156997","article-title":"Changes in the SHBG concentration during danazol treatment","volume":"123","author":"Gershagen","year":"1984","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"10.1016\/j.contraception.2008.04.004_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/bmj.308.6924.283","article-title":"The scandal of poor medical research","volume":"308","author":"Altman","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2008.04.004_bib18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2008.04.004_bib19","first-page":"379","article-title":"Cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators","volume":"2","author":"WHO","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2008.04.004_bib20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-8703(97)70105-4","article-title":"A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)","volume":"134","author":"Califf","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.contraception.2008.04.004_bib21","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(96)10488-8","article-title":"Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators","volume":"349","author":"Hampton","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2008.04.004_bib22","doi-asserted-by":"crossref","first-page":"605","DOI":"10.7326\/0003-4819-125-7-199610010-00011","article-title":"Surrogate end points in clinical trials: are we being misled?","volume":"125","author":"Fleming","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.contraception.2008.04.004_bib23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/sim.4780080407","article-title":"Surrogate endpoints in clinical trials: definition and operational criteria","volume":"8","author":"Prentice","year":"1989","journal-title":"Stat Med"},{"key":"10.1016\/j.contraception.2008.04.004_bib24","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1002\/(SICI)1097-0258(19981115)17:21<2435::AID-SIM994>3.3.CO;2-7","article-title":"Statistical issues for HIV surrogate endpoints: point\/counterpoint. An NIAID workshop","volume":"17","author":"Albert","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.contraception.2008.04.004_bib25","series-title":"Stedman's medical dictionary","year":"2000"},{"key":"10.1016\/j.contraception.2008.04.004_bib26","series-title":"Dorland's illustrated medical dictionary","year":"2003"},{"key":"10.1016\/j.contraception.2008.04.004_bib27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.04.004_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1373\/49.1.7","article-title":"The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration","volume":"49","author":"Bossuyt","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.contraception.2008.04.004_bib29","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0002-9378(16)32489-9","article-title":"Oral contraceptives and blood coagulation: a critical review","volume":"142","author":"Mammen","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2008.04.004_bib30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0010-7824(98)00020-1","article-title":"Blood coagulation and oral contraceptives. A critical review","volume":"57","author":"Winkler","year":"1998","journal-title":"Contraception"},{"issue":"Suppl 1","key":"10.1016\/j.contraception.2008.04.004_bib31","first-page":"170","article-title":"Thrombophilic mechanisms of OCs","author":"Comp","year":"1997","journal-title":"Int J Fertil Women's Med"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782408001613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782408001613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T14:08:06Z","timestamp":1557670086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782408001613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0010782408001613"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2008.04.004","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}